Journal article
Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR)
Annals of surgical oncology, Vol.29(8), pp.4688-4689
08/01/2022
DOI: 10.1245/s10434-022-11627-9
PMID: 35527328
Abstract
no abstract
Details
- Title: Subtitle
- Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR)
- Creators
- Tahsin M. Khan - National Institutes of HealthEmily A. Verbus - National Institutes of HealthSaumil Gandhi - The University of Texas MD Anderson Cancer CenterJohn V. Heymach - The University of Texas MD Anderson Cancer CenterJonathan M. Hernandez - National Institutes of HealthYasir Y. Elamin - The University of Texas MD Anderson Cancer Center
- Resource Type
- Journal article
- Publication Details
- Annals of surgical oncology, Vol.29(8), pp.4688-4689
- DOI
- 10.1245/s10434-022-11627-9
- PMID
- 35527328
- NLM abbreviation
- Ann Surg Oncol
- ISSN
- 1068-9265
- eISSN
- 1534-4681
- Publisher
- Springer Nature
- Number of pages
- 2
- Grant note
- ZIABC011861 / National Cancer Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
- Language
- English
- Date published
- 08/01/2022
- Academic Unit
- Surgery
- Record Identifier
- 9985224322302771
Metrics
2 Record Views